America Great Health (AAGH)
0.0029
0.00 (0.00%)
USD |
OTCM |
Mar 28, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 62.05M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -69.05% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 283.09 |
Price to Book Value | -- |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -0.3856 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.97% |
Profile
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem. |
URL | http://www.aaghus.com |
Investor Relations URL | N/A |
HQ State/Province | California |
Sector | Healthcare |
Industry | Biotechnology |
Equity Style | N/A |
Next Earnings Release | May. 22, 2024 (est.) |
Last Earnings Release | Nov. 17, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem. |
URL | http://www.aaghus.com |
Investor Relations URL | N/A |
HQ State/Province | California |
Sector | Healthcare |
Industry | Biotechnology |
Equity Style | N/A |
Next Earnings Release | May. 22, 2024 (est.) |
Last Earnings Release | Nov. 17, 2023 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |